文献速递心血管USMR

心脏影像学在安德森-法布里病诊断与管理中的作用

The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease.
PubMed 文献 · JACC Cardiovasc Imaging · 2019-01-01

安德森-法布里病(AFD)是X连锁遗传的罕见代谢病,因α-半乳糖苷酶A缺乏导致糖鞘脂在心脏等器官沉积,引起心肌炎症、左心室肥厚和心肌纤维化。超声心动图和心血管磁共振(CMR)用于识别AFD心脏表型、与其他左心室肥厚鉴别、选择治疗患者及监测药物疗效。先进心脏影像有望用于亚临床病变检测、疾病分期和预后判断。

要点

  • 超声心动图和CMR可识别AFD心脏表型并与其他原因的左心室肥厚鉴别。
  • 心脏影像可用于AFD患者治疗干预的选择和药物疗效监测。
  • 先进心脏影像有望用于AFD亚临床异常检测、疾病分期和预后判断。

核心结论

  • 超声心动图和CMR在AFD诊断、与其他左心室肥厚鉴别、治疗患者选择和药物疗效监测中具有互补价值,先进心脏影像有望用于亚临床检测、疾病分期和预后判断。

研究设计与样本

  • 综述类文章,未报告系统检索范围与纳入文献数量。

关键影像表现/征象

  • AFD心脏受累常见,表现为心肌炎症增加、左心室肥厚(LVH)和心肌纤维化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Anderson-Fabry disease (AFD) is a rare X-linked inherited metabolic disorder which results in a deficiency or absence of the enzyme α-galactosidase A, leading to the accumulation of glycosphingolipids in various cells and organs including the heart. Cardiac involvement is common and results in increased myocardial inflammation, left ventricular hypertrophy (LVH), and myocardial fibrosis. Echocardiography and cardiovascular magnetic resonance (CMR) offer distinctive and often complementary use to assist in the diagnosis and monitoring pharmacologic therapy in AFD, including detection of the AFD cardiac phenotype, differentiation from other forms of LVH, and patient selection for therapeutic intervention. Advanced cardiac imaging holds promise in subclinical detection of AFD-related abnormalities as well as disease staging and prognostication.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Perry R, Shah R, Saiedi M, et al. The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease. JACC Cardiovasc Imaging. 2019. PMID: 31272606. doi:10.1016/j.jcmg.2018.11.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。